Oxazepam: Clinical Trials

9 trials of Oxazepam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated, 1 unknown. 5 Phase 1, 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 32Terminated 1, Unknown 1
Not applicable1Completed 1
Phase 21Unknown 1
Phase 41Completed 1

Follow Oxazepam: new trials by email Literature Review of Oxazepam trials Research Report on Oxazepam

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
EMB-01 - Smoking Cessation, Tobacco Use Disorder
Phase 2 / Phase 3UnknownRose Research Center, LLC252021-05-192021-05-28
A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
EMB-001, Placebo, Cocaine IV - Cocaine Use Disorder
Phase 1CompletedEmbera NeuroTherapeutics, Inc.182016-07-012017-08-01
Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)
metyrapone & oxazepam, Placebo - Cocaine Use Disorder, Tobacco Use Disorder
Phase 1CompletedEmbera NeuroTherapeutics, Inc.242015-03-012016-07-22
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers
Jelly with:Paracetamol, Jelly with Furosemide, Jelly with Levothyroxine sodium salt - Healthy
Phase 1CompletedCentre Hospitalier Universitaire de Nice162014-06-012015-10-07
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
Metyrapone, Oxazepam, Placebo - Cocaine Dependence, Cocaine Addiction
Not applicableCompletedEmbera NeuroTherapeutics, Inc.452007-12-012026-09-18
Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets
Songha® Night, Oxazepam, Placebo - Healthy
Phase 1CompletedBoehringer Ingelheim542003-02-012014-10-24
Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome
Sodium Oxybate (SMO), Oxazepam - Alcohol Withdrawal Syndrome, Alcohol Dependence
Phase 4CompletedCatholic University of the Sacred Heart1272002-02-012014-03-18
The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
Oxazepam, Zidovudine - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)82008-08-04

Conditions studied

Tobacco Use Disorder (2)  ·  Alcoholism (1)  ·  Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Cocaine-Related Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  HIV Infections (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Smoking Cessation (1)

Sponsors

Embera NeuroTherapeutics, Inc. (3)  ·  Boehringer Ingelheim (1)  ·  Catholic University of the Sacred Heart (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Hannover Medical School (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rose Research Center, LLC (1)

Countries

United States (5)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Anita S Kablinger, MD (1)  ·  Blaschke T (1)  ·  Debra Kelsh, MD (1)  ·  Gary Connor, RN (1)  ·  Giovanni Addolorato, MD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Israelski D (1)  ·  Otto Lesch, MD, Prof. (1)

Results publications

PMID 24996524

NIH funding

R01DA030932 (1), U01DA038879 (1)